We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

180 hedge funds and large institutions have $744M invested in Meridian Bioscience Inc in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 72 increasing their positions, 43 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

67% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 43

5% more funds holding

Funds holding: 172 → 180 (+8)

7% less capital invested

Capital invested by funds: $802M → $744M (-$57.4M)

37% less call options, than puts

Call options by funds: $1.2M | Put options by funds: $1.89M

Holders
180
Holders Change
+8
Holders Change %
+4.65%
% of All Funds
4.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
72
Reduced
43
Closed
14
Calls
$1.2M
Puts
$1.89M
Net Calls
-$693K
Net Calls Change
-$2.02M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.47M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.37M
3
Citadel Advisors
Citadel Advisors
Florida
+$2.63M
4
Norges Bank
Norges Bank
Norway
+$2.32M
5
AI
Analytic Investors
California
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$19.3M
2
Neuberger Berman Group
Neuberger Berman Group
New York
-$16.3M
3
MCM
McKinley Capital Management
Alaska
-$6.82M
4
PCM
Piermont Capital Management
Missouri
-$2.45M
5
Fifth Third Bancorp
Fifth Third Bancorp
Ohio
-$1.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$5.15M +$2.63M +134,153 +103%
ICOM
27
Investment Counselors of Maryland
Maryland
$4.85M – – –
AI
28
Analytic Investors
California
$4.63M +$1.91M +97,247 +69%
CAM
29
Capstone Asset Management
Texas
$4.59M +$107K +5,473 +2%
Wells Fargo
30
Wells Fargo
California
$4.18M +$417K +21,274 +11%
NFA
31
Nationwide Fund Advisors
Ohio
$4.13M +$8.57K +437 +0.2%
Ameriprise
32
Ameriprise
Minnesota
$4.1M +$143K +7,285 +4%
GF
33
Gabelli Funds
New York
$3.98M – – –
EA
34
Emerald Acquisition
Washington
$3.87M +$3.89M +198,486 New
BIM
35
BlackRock Investment Management
Delaware
$3.47M +$285K +14,548 +9%
CIS
36
Connors Investor Services
Pennsylvania
$2.94M -$21.3K -1,084 -0.7%
MIP
37
Mondrian Investment Partners
United Kingdom
$2.92M +$343K +17,502 +13%
New York State Teachers Retirement System (NYSTRS)
38
New York State Teachers Retirement System (NYSTRS)
New York
$2.92M – – –
PAM
39
Panagora Asset Management
Massachusetts
$2.89M -$283K -14,450 -9%
GCP
40
GSA Capital Partners
United Kingdom
$2.77M +$785K +40,024 +39%
JP Morgan Chase
41
JP Morgan Chase
New York
$2.75M -$1.89M -96,328 -41%
GI
42
GAMCO Investors
Connecticut
$2.73M – – –
TA
43
Teton Advisors
New York
$2.73M – – –
HighTower Advisors
44
HighTower Advisors
Illinois
$2.61M +$233K +11,888 +10%
TCIM
45
TIAA CREF Investment Management
New York
$2.57M -$82.2K -4,194 -3%
Deutsche Bank
46
Deutsche Bank
Germany
$2.47M +$570K +29,083 +30%
ZAM
47
Zevin Asset Management
Massachusetts
$2.43M +$83K +4,230 +4%
MC
48
Menta Capital
California
$2.39M +$485K +24,739 +25%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$2.38M +$18.4K +940 +0.8%
PPA
50
Parametric Portfolio Associates
Washington
$2.32M +$43.3K +2,210 +2%
1
2
3 4 5

VIVO Hedge Fund Activity: Q2 2016 in Review

180 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2016, worth a combined $744M — down 7.2% from $802M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new VIVO positions and 14 closed out — a net gain of 11 holders — while 72 added to existing stakes and 43 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.47M. The largest seller was Schroder Investment Management Group, cutting an estimated $19.3M.

  • 180 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2016, up from 172 in Q1 2016.
  • Funds reported $744M of Meridian Bioscience Inc stock for Q2 2016, down 7.2% quarter-over-quarter.
  • 25 funds opened new Meridian Bioscience Inc positions in Q2 2016 and 14 closed out, a net change of +11 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2016 was Morgan Stanley, an estimated $3.47M added.
  • The largest Meridian Bioscience Inc seller in Q2 2016 was Schroder Investment Management Group, an estimated $19.3M sold.

Based on aggregated 13F filings for Q2 2016.